We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

166 hedge funds and large institutions have $1.9B invested in Medicines Co in 2014 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

64% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 25

25% more capital invested

Capital invested by funds: $1.52B → $1.9B (+$382M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9% more funds holding

Funds holding: 152166 (+14)

51% less call options, than puts

Call options by funds: $6.41M | Put options by funds: $13M

Holders
166
Holders Change
+14
Holders Change %
+9.21%
% of All Funds
4.43%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
41
Increased
57
Reduced
50
Closed
25
Calls
$6.41M
Puts
$13M
Net Calls
-$6.59M
Net Calls Change
+$4.63M
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Teachers Retirement System (NYSTRS)
76
New York State Teachers Retirement System (NYSTRS)
New York
$2.35M +$96.6K +3,900 +5%
PAMU
77
Pictet Asset Management (UK)
United Kingdom
$2.32M +$89.2K +3,600 +4%
TD Asset Management
78
TD Asset Management
Ontario, Canada
$2.25M +$102K +4,100 +5%
Allianz Asset Management
79
Allianz Asset Management
Germany
$2.22M +$847K +34,170 +74%
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
$2.12M -$59.8K -2,415 -3%
CS
81
Candriam SCA
Luxembourg
$2.08M +$1.86M +75,000 New
MOACM
82
Mutual of America Capital Management
New York
$2.04M +$541K +21,821 +42%
Swiss National Bank
83
Swiss National Bank
Switzerland
$1.93M +$44.6K +1,800 +3%
BG
84
BlackRock Group
United Kingdom
$1.75M +$89.2K +3,600 +6%
SIM
85
Spark Investment Management
New York
$1.64M -$389K -15,700 -21%
ProShare Advisors
86
ProShare Advisors
Maryland
$1.63M -$51.7K -2,087 -3%
TPSF
87
Texas Permanent School Fund
Texas
$1.63M -$1.51K -61 -0.1%
American Century Companies
88
American Century Companies
Missouri
$1.6M +$47.2K +1,905 +3%
FM
89
Forward Management
California
$1.59M +$1.58M +63,835 New
State Board of Administration of Florida Retirement System
90
State Board of Administration of Florida Retirement System
Florida
$1.49M -$6.71K -271 -0.5%
TRSOTSOK
91
Teachers Retirement System of the State of Kentucky
Kentucky
$1.48M
USAA
92
United Services Automobile Association
Texas
$1.45M +$115K +4,640 +10%
Barclays
93
Barclays
United Kingdom
$1.44M -$1.39M -56,164 -51%
State of Tennessee, Department of Treasury
94
State of Tennessee, Department of Treasury
Tennessee
$1.41M -$124K -5,000 -9%
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$1.4M
ABI
96
Adamant Biomedical Investments
Switzerland
$1.38M
AIG
97
American International Group
New York
$1.34M -$35K -1,412 -3%
CS
98
Credit Suisse
Switzerland
$1.34M -$914K -36,887 -43%
Marshall Wace
99
Marshall Wace
United Kingdom
$1.28M +$1.15M +46,226 New
ASRS
100
Arizona State Retirement System
Arizona
$1.26M +$14.9K +600 +1%

MDCO Hedge Fund Activity: Q4 2014 in Review

166 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2014, worth a combined $1.9B — up 25% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new MDCO positions and 25 closed out — a net gain of 16 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was PointState Capital, adding an estimated $33.1M. The largest seller was Fidelity Investments, cutting an estimated $71.2M.

  • 166 institutional investors held Medicines Co (MDCO) as of Q4 2014, up from 152 in Q3 2014.
  • Funds reported $1.9B of Medicines Co stock for Q4 2014, up 25% quarter-over-quarter.
  • 41 funds opened new Medicines Co positions in Q4 2014 and 25 closed out, a net change of +16 holders.
  • The largest Medicines Co buyer in Q4 2014 was PointState Capital, an estimated $33.1M added.
  • The largest Medicines Co seller in Q4 2014 was Fidelity Investments, an estimated $71.2M sold.

Based on aggregated 13F filings for Q4 2014.